|
Originally published In Press as doi:10.1074/jbc.M100585200 on June 25, 2001
J. Biol. Chem., Vol. 276, Issue 36, 34051-34058, September 7, 2001
Protein Tyrosine Nitration in Cytokine-activated Murine
Macrophages
INVOLVEMENT OF A PEROXIDASE/NITRITE PATHWAY RATHER THAN
PEROXYNITRITE*
Silvia
Pfeiffer ,
Achim
Lass,
Kurt
Schmidt, and
Bernd
Mayer§
From the Institut für Pharmakologie und Toxikologie,
Karl-Franzens-Universität Graz, Universitätsplatz 2, A-8010 Graz, Austria
Received for publication, January 22, 2001, and in revised form, April 24, 2001
 |
ABSTRACT |
Peroxynitrite, formed in a rapid reaction of
nitric oxide (NO) and superoxide anion radical (O 2), is
thought to mediate protein tyrosine nitration in various inflammatory
and infectious diseases. However, a recent in vitro study
indicated that peroxynitrite exhibits poor nitrating efficiency at
biologically relevant steady-state concentrations (Pfeiffer, S.,
Schmidt, K., and Mayer, B. (2000) J. Biol. Chem. 275, 6346-6352). To investigate the molecular mechanism of protein tyrosine
nitration in intact cells, murine RAW 264.7 macrophages were
activated with immunological stimuli, causing inducible NO synthase
expression (interferon- in combination with either
lipopolysaccharide or zymosan A), followed by the determination of
protein-bound 3-nitrotyrosine levels and release of potential triggers
of nitration (NO, O 2, H2O2,
peroxynitrite, and nitrite). Levels of 3-nitrotyrosine started to
increase at 16-18 h and exhibited a maximum at 20-24 h
post-stimulation. Formation of O 2 was maximal at 1-5 h and
decreased to base line 5 h after stimulation. Release of NO peaked
at ~6 and ~9 h after stimulation with
interferon- /lipopolysaccharide and interferon- /zymosan A,
respectively, followed by a rapid decline to base line within the next
4 h. NO formation resulted in accumulation of nitrite, which
leveled off at about 50 µM 15 h post-stimulation.
Significant release of peroxynitrite was detectable only upon treatment
of cytokine-activated cells with phorbol 12-myristate-13-acetate, which
led to a 2.2-fold increase in dihydrorhodamine oxidation without
significantly increasing the levels of 3-nitrotyrosine. Tyrosine
nitration was inhibited by azide and catalase and mimicked by
incubation of unstimulated cells with nitrite. Together with the
striking discrepancy in the time course of
NO/O 2 release versus 3-nitrotyrosine
formation, these results suggest that protein tyrosine nitration in
activated macrophages is caused by a nitrite-dependent peroxidase reaction rather than peroxynitrite.
 |
INTRODUCTION |
The free radical nitric oxide (NO) is produced by constitutive and
inducible nitric-oxide synthases and regulates numerous biological
processes, including relaxation of blood vessels and neurotransmitter
release in the brain. However, overproduction of NO appears to
contribute essentially to tissue injury in inflammatory and ischemic
conditions (1). One of the mechanisms by which excess NO can injure
tissues is by its nearly diffusion-controlled reaction with O 2
to give peroxynitrite, a potent oxidant thought to be a key mediator of
NO-mediated tissue injury in atherosclerosis, congestive heart failure,
glutamate excitotoxicity, and other disease states involving
inflammatory oxidative stress (2). There are several pieces of evidence
implicating peroxynitrite as toxic agent in these pathologies as
follows. (i) All of these diseases are associated with increased
expression of inducible NO synthase, resulting in sustained formation
of NO over relatively long periods of time, (ii) oxidative stress
causes increased generation of O 2, (iii) authentic
peroxynitrite triggers tyrosine nitration of a wide variety of proteins
known to subserve important cellular functions that are lost upon
nitration, and (iv) 3-nitrotyrosine levels have been observed in the
injured tissues by both immunohistochemical techniques and quantitative
analyses with HPLC1 or gas
chromatography-mass spectrometry (3).
Despite this apparently conclusive link between oxidative tissue
injury, peroxynitrite, and tyrosine nitration, direct evidence for
peroxynitrite-mediated nitration in vivo is still lacking (4, 5). This is of particular relevance because recent in vitro studies suggest that co-generation of NO and O 2, an
obviously better approximation to the in vivo situation than
bolus addition of concentrated peroxynitrite solutions, does not cause
significant nitration of free tyrosine (6-10). Although all of those
studies, performed in four independent laboratories with a number of
different NO/O 2-generating systems including pulse radiolysis,
gave essentially identical results, Sawa et al. (11)
recently reported on highly efficient tyrosine nitration by low fluxes
of NO/O 2. The reason for this discrepancy is unclear.
The striking difference between peroxynitrite generated in
situ at relatively low fluxes and bolus addition of authentic
peroxynitrite appears to be a consequence of the different steady-state
concentrations that are achieved with the two experimental protocols;
at low (submicromolar) steady-state concentrations, the reaction of
peroxynitrite with tyrosine was found to give almost exclusively
dityrosine, i.e. the product of tyrosyl radical
dimerization, whereas 3-nitrotyrosine is the major product at the
fairly high concentrations of peroxynitrite that occur upon bolus
addition of the authentic compound (8).
Recent studies have revealed an alternative mechanism of tyrosine
nitration with potential in vivo relevance (4). Heme peroxidases such as myeloperoxidase or eosinophil peroxidase have been
shown to utilize H2O2 to oxidize nitrite to a
reactive nitrogen oxide species that triggers nitration of protein
tyrosine residues and other phenolic compounds (12-14). Since
inflammatory processes are typically associated with an infiltration of
phagocytes, which contain high levels of heme peroxidases, this pathway
has to be considered as a possible alternative to peroxynitrite in
mediating protein tyrosine nitration in vivo. Intriguingly,
the dependence of peroxidase-catalyzed nitration on the local levels of
NO and H2O2
suggests that the peroxidase pathway operates under exactly the
conditions that favor formation of peroxynitrite, i.e.
increased formation of both NO and O 2, the reactive precursors
of NO and
H2O2, respectively.
Thus, the experimental evidence currently available does not allow a
decision as to which of the two pathways is responsible for tyrosine
nitration in vivo. Although several in vitro
studies with NO/O 2-generating systems (see above) argue
against peroxynitrite as a mediator of nitration, it should be
emphasized that those studies were performed with highly artificial
in vitro systems not necessarily reflecting the in
vivo situation. As a first approach in addressing this
issue, we attempted to clarify the cellular pathways mediating protein
tyrosine nitration in cultured macrophages activated with established
immunological stimuli. As a model system we used the murine macrophage
RAW 264.7 cell line. These cells are known to express high levels of
inducible NO synthase and 3-nitrotyrosine-like immunoreactivity in
response to immunological challenge with IFN- in combination with
LPS or zymosan (15). Upon cell activation, we measured several key
parameters of the NO/O 2/peroxynitrite pathway as a function
of time and compared the data with protein tyrosine nitration. These
experiments revealed a striking discrepancy in the time course of NO
formation and nitration and showed that peroxidase inhibitors as well
as catalase attenuated the formation of 3-nitrotyrosine, whereas
peroxynitrite scavengers had no significant effects. Based on these
results we suggest that tyrosine nitration in cytokine-activated
macrophages is mediated by a peroxidase/nitrite pathway rather than
NO/O 2-derived peroxynitrite.
 |
EXPERIMENTAL PROCEDURES |
Materials--
DHR and 3-nitrotyrosine were from Fluka (Vienna,
Austria). Recombinant mouse IFN- and pronase were from Roche
Molecular Biochemicals (Vienna, Austria). MnTBAP was from Alexis
(Vienna, Austria). Rabbit anti-human myeloperoxidase antibody was from
DAKO (Vienna, Austria). Human myeloperoxidase was from Planta
Naturstoffe (Vienna, Austria). The 3-nitrotyrosine antibody (clone 1A6,
mouse monoclonal IgG, 100 µg/100 µl) was from Upstate Biotechnology
(Lake Placid, NY). Penicillin, amphotericin, and fetal calf serum were
from PAA Laboratories GmbH (Linz, Austria). The ECL Western blotting
detection system was obtained from Amersham Pharmacia Biotech.
Centrifuge tube filters (0.22 µm cellulose acetate) were from Szabo
(Vienna, Austria). Lipopolysaccharide was from Salmonella
typhosa; bovine erythrocytes SOD, horse heart cytochrome
c (type VI), and all other chemicals were from Sigma.
PEG-Cat and PEG-SOD were prepared according to Beckman et
al. (16).
Buffers and Solutions--
All solutions were prepared freshly
each day. Water was from a Milli-Q reagent water system from Millipore
(Vienna, Austria; resistance 18 megaohms × cm 1). DHR was dissolved in acetonitrile to 10 mM and kept in the dark until use. MnTBAP was dissolved in
methanol to 0.1 M. PBS was 8 mM
Na2HPO4, 1.5 mM
KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4. Krebs-Ringer phosphate buffer was 129 mM NaCl, 4.86 mM KCl, 0.54 mM
CaCl2, 1.22 mM MgSO4, 15.8 mM NaH2PO4, pH 7.35. TBST was 20 mM Tris/HCl, 137 mM NaCl, 0.05% (w/v) Tween
20, pH 7.7.
Culture and Activation of Macrophages--
RAW 264.7 macrophages
were cultured in Petri dishes (diameter, 90 mm) at 37 °C and 5%
CO2 in Dulbecco's modified Eagle's medium supplemented
with 10% (v/v) heat-inactivated fetal calf serum, penicillin (100 units/ml), amphotericin (1.25 µg/ml), and NaHCO3 (3.7 g/l) as described (17). Cells were grown to confluence (~5 × 107 cells/dish) and incubated for up to 48 h in the
presence of IFN- (50 units/ml) and either LPS (0.5 µg/ml) or
zymosan A (0.5 mg/ml) in fresh phenol red-free Dulbecco's modified
Eagle's medium. At the time points indicated in the text and graphs,
the activated cells were assayed for the following parameters: nitrite
accumulation in the culture medium, release of NO, O 2, and
H2O2, DHR oxidation, and intracellular levels
of protein-bound 3-nitrotyrosine.
Determination of Nitrite Accumulation--
The concentration of
nitrite in the cell culture supernatants was determined photometrically
with the Griess assay as described previously (18).
Determination of NO Release--
The culture medium was removed,
and the cells (one Petri dish for each measurement) were washed with
PBS, harvested, centrifuged, and resuspended in 0.5 ml of PBS. NO
release was continuously monitored with a Clark-type NO-sensitive
electrode (Iso-NO, World Precision Instruments, Berlin, Germany) at
37 °C in disposable tubes (19). After 1 min, 5 µl of a 0.1 M solution of L-arginine (final concentration,
1 mM) was injected. NO formation was quantified from the
initial release rates obtained after injection of
L-arginine using the Macintosh CHART software.
Determination of O 2 Release--
Rates of O 2
release were measured as PEG-SOD-inhibitable reduction of acetylated
cytochrome c as described (20). At the indicated time
points, the cells were washed three times and equilibrated for 30 min
in PBS followed by incubation with 10 µM acetylated cytochrome c for 45 min with and without 150 units of
PEG-SOD/ml. The cell supernatants were centrifuged at 1,300 × g for 3 min followed by the determination of the absorbance
at 550 nm against PEG-SOD-containing blanks. PEG-SOD inhibited total
cytochrome c reduction by ~80%. O 2 release was
calculated using an extinction coefficient of 27,700 M 1 × cm 1 at 550 nm (21).
Determination of H2O2
Formation--
Formation of H2O2 was measured
as horseradish peroxidase-catalyzed oxidation of fluorescent scopoletin
as described (22). At the indicated time points, macrophages were
washed three times with PBS and incubated for 45 min with an assay
mixture containing 30 µM scopoletin, 1 mM
NaN3, and 10 units/ml horseradish peroxidase in
Krebs-Ringer phosphate buffer. Supernatants were centrifuged at
1,300 × g for 3 min followed by the determination of
the fluorescence at excitation and emission wavelengths of 305 and 470 nm, respectively. The fluorescence of the assay mixture without cells
was subtracted as the blank. The method was calibrated with standard
solutions of H2O2 adjusted photometrically
using an extinction coefficient of 40 M 1 × cm 1 at 240 nm.
Determination of DHR Oxidation--
Oxidation of DHR was
determined as a measure of peroxynitrite formation (23). At
the indicated time points, the cells were washed three times with PBS
and incubated for 45 min in PBS containing 0.1 mM DHR and
0.1 mM of the metal chelator diethylenetriaminepentaacetic acid. The cell supernatants were centrifuged at 1,300 × g for 3 min followed by determination of the absorbance at
500 nm against blank samples obtained by incubation of the assay
mixture without cells. DHR oxidation was calculated using an extinction
coefficient of 78,800 M 1 × cm 1
at 500 nm (23).
Determination of Protein-bound
3-Nitrotyrosine--
Protein-bound 3-nitrotyrosine was determined by
HPLC with electrochemical detection after derivatization to
N-AcATyr following a protocol described recently (24). The
cells were homogenized in 0.1 M phosphate buffer, pH 7.4, and adjusted to a protein concentration of 16-30 mg of protein/ml.
Protein was determined with the Bradford method using bovine serum
albumin as a standard (25). Homogenates (0. 5 ml) were
precipitated with 0.6 ml of HPLC grade acetonitrile, thoroughly
vortexed and centrifuged (1000 × g), followed by
resuspension of the precipitates in 0.1 M phosphate buffer,
pH 7.4, and sonication for ~10 s at 50 watts. This procedure was
repeated three times to efficiently wash out non-protein material. The
final suspensions were incubated overnight (16-20 h) at 50 °C with
1-2 mg of pronase and 0.5 mM CaCl2.
Subsequently, 350-µl aliquots of the samples were centrifuged
(20,000 × g), and an equal volume of 3 M
phosphate buffer, pH 9.6, was added followed by the addition of 25 µl
of acetic anhydride. After 10 min of incubation at ambient temperature, ethyl acetate (1 ml) and formic acid (0.2 ml) were added. The samples
were thoroughly vortexed for 30 s and then centrifuged at
20,000 × g for 1 min. The ethyl acetate phase was
concentrated to dryness under a gentle stream of N2 at
50 °C. For deacetylation of the phenolic acetate group, the samples
were resuspended in 1 N NaOH (60 µl). After 30 min of
incubation at 37 °C, 60 µl of 1 M phosphate buffer, pH
6.5, was added followed by the addition of 0.1 M sodium
dithionite (10 µl) to reduce the nitro substituent to the
corresponding amine. The samples were incubated for 10 min at ambient
temperature, acidified by addition of concentrated hydrochloric acid
(20 µl), and centrifuged at 20,000 × g for 10 min in
centrifuge tube filters. Aliquots (100 µl) were injected onto a
250 × 4 mm C18 reversed phase HPLC column
(LiChrospher 100 RP-18, 5-µm particle size, Merck) and eluted with 10 mM H3PO4 at 0.7 ml/min. The
performance of the column decreased gradually over time. This loss in
resolution was overcome by supplementing the solvent with up to 2%
(v/v) methanol. N-AcATyr was detected electrochemically with
an ESA Coulochem II detector. The potentials of the two electrodes were
set to 70 mV and +70 mV (versus palladium), respectively.
The method was calibrated daily with authentic N-AcATyr (5-500 nM) prepared as described (24). The recovery of
authentic 3-nitrotyrosine added to homogenates of resting RAW 264.7 macrophages was 69.3 ± 12.8%.
Immunostaining--
To visualize 3-nitrotyrosine formation, RAW
264.7 macrophages were subjected to immunostaining with a monoclonal
antibody. The cells were grown to confluence on
L-polylysine-treated cover slides followed by activation
with IFN- /Zy in phenol red-free Dulbecco's modified Eagle's medium
for 24 h. After 14 h of activation the test compounds
(methionine, 0.25 mM; MnTBAP, 50 µM; KCN, 0, 25 mM; NaN3, 0, 25 mM, and PEG-Cat,
2000 units/ml) were added followed by incubation for a further 10 h. As a negative control, non-activated macrophages were incubated
under identical conditions for 24 h. For positive control, the
cells were treated with authentic peroxynitrite (1 mM) for
1 h. After incubation, the cover slides were gently rinsed three
times with PBS and fixed for 1 h with a solution, pH 6.5, containing Na2HPO4 (6.5 g/liter),
NaH2PO4 (4 g/liter), (v/v) 15 ml/liter methanol
(15 ml/liter; v/v), and formaldehyde (100 ml of 37%/liter, v/v).
Thereafter, cover slides were gently rinsed three times with PBS. The
3-nitrotyrosine antibody was diluted to 10 µg/ml in PBS containing
1% bovine serum albumin (w/v). 50 µl of this solution were carefully
applied to each cover slide to cover the entire surface and incubated
for 1 h at 37 °C under humidified atmosphere. After gentle
rinsing of the cover slides three times with PBS, 50 µl of
biotinylated goat anti-mouse IgG (part of the mouse ExtrAvidin
peroxidase staining kit obtained from Sigma diluted 1/20 in PBS
containing 1% bovine serum albumin) were applied on the cover slides
and incubated for 30 min at 37 °C under a humidified atmosphere.
Then cover slides were again gently rinsed three times with PBS
followed by the application of 100 µl of ExtrAvidin peroxidase (10 µg/ml in PBS) on each cover slide and incubation for 30 min at
37 °C under humidified atmosphere and rinsing of the slides with
PBS. The staining solution was prepared by mixing 0.2 ml of 20 mg of
3-amino-9-ethylcarbazole in 2.5 ml of dimethylformamide with 3.8 ml of
0.05 M acetate buffer, pH 5.0. Before use, 20 µl of 3%
(v/v) H2O2 were added to the staining solution,
and 100 µl were applied on the cover slides until the appropriate
color development (3-4 min). Reactions were terminated by rinsing the
slides gently with distilled water.
SDS-Polyacrylamide Gel Electrophoresis and
Immunoblotting--
Cell homogenates were subjected to
SDS-polyacrylamide gel electrophoresis on 12% slab gels (26) and
transferred onto nitrocellulose membranes in 25 mM
Tris/HCl, pH 8.3, containing 192 mM glycine, 0.02% (w/v)
SDS, and 20% (v/v) methanol at 250 mA for 90 min. Unspecific binding
sites were saturated by overnight incubation of the membranes at
4 °C in TBST containing 3% (w/v) ovalbumin. Subsequently, the
membranes were washed twice for 5 min followed by incubation for 2 h with the anti-myeloperoxidase antibody diluted 1:500 in TBST
containing 0.3% (w/v) ovalbumin. Subsequently, the membranes were
washed twice for 15 min with TBST and incubated for 1 h with
horseradish peroxidase-labeled anti-rabbit-IgG antibody that had been
diluted 1:5000 in TBST buffer containing 0.3% (w/v) ovalbumin.
Finally, the membranes were washed three times for 20 min with TBST
buffer and processed with the ECL Western-blotting detection system
according to the recommendations of Amersham Pharmacia Biotech.
Data Analysis and Statistics--
Unless otherwise indicated,
release rates are expressed as amounts of product (pmol or pg)/min/mg
of total cell protein. Results are the mean values ± S.E. of
n experiments as indicated in the figure legends. The
statistical significance of the data shown in Fig. 6 was evaluated by
analysis of variance using Fisher's protected least significant
difference test.
 |
RESULTS |
Time Course of NO and NO
Formation by Activated Macrophages--
Activation of RAW 264.7 macrophages with either IFN- /LPS or IFN- /Zy led to a pronounced
release of NO accompanied by an accumulation of nitrite in the cell
culture media. As shown in Fig.
1A, the maximal rates of NO
release were 116.2 ± 15.0 and 90.9 ± 11.5 pmol × min 1 × mg 1 at 7 and 9 h after
stimulation with IFN- /LPS and IFN- /Zy, respectively. Note that
with both stimuli, NO release was virtually back to base line after
14 h of incubation. The inset in Fig. 1A
shows that NO release was markedly increased upon the addition of
L-arginine, an observation that agrees well with previous
studies reporting on a pronounced dependence of macrophage NO synthesis
on extracellular substrate supply (27, 28). NO release was not
significantly affected by the addition of SOD (1000 units/ml). The
signal rapidly declined to zero upon the addition of the NO scavenger
hemoglobin, demonstrating the specificity of the Clark-type NO
electrode.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
Formation of NO and nitrite by murine RAW
264.7 macrophages activated with IFN- /LPS or
IFN- /Zy. A, macrophages were
incubated in the presence of IFN- /LPS (open symbols) or
IFN- /Zy (filled symbols) for up to 24 h, washed with
PBS, centrifuged, and resuspended in 0.5 ml of PBS. NO release was
measured with a Clark-type NO-sensitive electrode at 37 °C upon the
addition of a 0.1 M L-arginine solution (5 µl) at the indicated time points. The formation of NO was quantified
from the initial release rates as described under "Experimental
Procedures." The data are the mean values ± S.E. of four
experiments. Inset, original traces obtained with cells
incubated for 7 h with IFN- /LPS (solid line) or
IFN- /Zy (dotted line). L-arginine (0.1 mM), SOD (1000 units/ml), and hemoglobin (Hb; 20 µM) were added at the time points indicated by
arrows. B, macrophages were incubated in the
presence of IFN- /LPS (open symbols) or IFN- /Zy
(filled symbols) for up to 24 h. At the indicated time
points, nitrite concentrations were determined in the cell culture
supernatants photometrically with the Griess assay as described
under "Experimental Procedures." The data are the mean values ± S.E. of four experiments.
|
|
The time course of nitrite accumulation in the cell culture supernatant
was virtually identical with both combinations of stimuli (Fig.
1B). Nitrite levels progressively increased from 4 to
15 h of incubation followed by a plateau corresponding to nitrite
concentrations of about 50 µM. Conversion of the rates of
NO release from macrophages activated with either cytokine combination
(Fig. 1A) to accumulating concentrations revealed that the
decrease in the rates of NO release is in good accordance with the
observed reduction in the rate of nitrite accumulation; based on the
nitrite data, the apparent recovery of NO detected with the Clark
electrode was ~50% (not shown). These results indicate that
macrophage NO synthesis ceased after about 15 h of cell
activation, presumably due to inducible NO synthase inactivation
and/or limiting cofactor supply. Interestingly, the small but
significant rightward shift of the time course of NO release from
macrophages activated with IFN- /Zy- as compared with that from
IFN- /LPS-stimulated cells was not paralleled by a significant
difference in the time course of nitrite accumulation, suggesting that
specific intracellular pathways may affect net NO release from
activated macrophages. The differences in the kinetics of O 2
release were considered as an obvious explanation.
Time Course of O 2 and H2O2
Formation--
Activation of macrophages with IFN- /Zy led to a
burst of O 2 production (26.5 ± 3.5 pmol × min 1 × mg 1) during the first hour of
stimulation followed by a steady decline that reached basal rates (~2
pmol × min 1 × mg 1) after 7 h
(Fig. 2A). Release of
O 2 from cells stimulated with IFN- /LPS was much less
pronounced. The maximal rate of 12.8 ± 1.6 pmol × min 1 × mg 1 observed 2 h
post-stimulation had declined to basal rates 4 h after
stimulation. As shown in Fig. 2B, the time course of
H2O2 formation was similar to that of
O 2 with both stimulation protocols, but the overall fluxes
were ~1000-fold higher (note the different scales in the two
y axes of Fig. 2B).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 2.
Formation of O 2 and
H2O2 by macrophages activated with
IFN- /LPS or
IFN- /Zy. Macrophages were incubated in
the presence of IFN- /LPS (open symbols) or IFN- /Zy
(filled symbols) for up to 24 h. The data are the mean
values ± S.E. of three experiments. A, at the
indicated time points, PEG-SOD inhibitable reduction of acetylated
cytochrome c was determined as described under
"Experimental Procedures." Inset, data obtained in the
absence and presence of 1 mM L-NNA 7 h after the
addition of IFN- /LPS (open columns) or IFN- /Zy
(hatched columns). B, at the indicated time
points, H2O2 formation was measured with the
scopoletin fluorescence assay as described under "Experimental
Procedures."
|
|
We considered the possibility that the apparent decrease in O 2
formation was a consequence of a rapid reaction of O 2 with NO
to yield peroxynitrite and carried out two sets of experiments to test
this hypothesis. First, we repeated the experiments shown in Fig.
2A using cells treated with a high concentration of a non-selective NO synthase inhibitor (L-NNA; 1 mM). L-NNA
almost completely inhibited nitrite accumulation in the cell culture supernatant (data not shown) but had no effect on the rates of O 2 release measured 7 h after cell stimulation
(inset to Fig. 2A). Secondly, we determined the
time course of DHR oxidation as a measure for peroxynitrite formation.
Neither of the two protocols of macrophage activation (IFN- /LPS and
IFN- /Zy) resulted in a considerable increase in the rates of DHR
oxidation (1-3 pmol × min 1 × mg 1),
which was insensitive to L-NNA (data not shown). Together, these
results argue against peroxynitrite as a major reactive nitrogen
species formed by activated macrophages.
Evidence against the Involvement of Peroxynitrite in Tyrosine
Nitration--
Protein-bound 3-nitrotyrosine was measured in the cell
extracts as the N-acetyl-amino derivative
(N-AcATyr). As expected, treatment of macrophages with
authentic peroxynitrite (1 mM final) resulted in a
pronounced increase in tyrosine nitration from 19.4 ± 17.3 to
855.9 ± 270.2 pg of N-AcATyr/mg of cellular protein (n = 3 each). Fig. 3
shows that a significant increase in nitration was also observed upon
activation of the macrophages with either IFN- /Zy or IFN- /LPS.
The time course of N-AcATyr formation was similar with both
combinations of stimuli, although IFN- /Zy led to about a 3-fold
higher product formation than IFN- /LPS (385.3 ± 77.8 and
127.9 ± 8.7 pg × mg 1, respectively).
Nitration occurred with a pronounced lag phase of 6 (IFN- /Zy) to
18 h (IFN- /LPS), was maximal 24 h post-stimulation, and
slowly declined during the next 24 h.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Tyrosine nitration by macrophages activated
with IFN- /LPS or
IFN- /Zy. Macrophages were incubated in
the presence of IFN- /LPS (open symbols) or IFN- /Zy
(filled symbols) for up to 48 h. At the indicated time
points, protein-bound 3-nitrotyrosine was determined as
N-AcATyr derivative by HPLC and electrochemical detection as
described under "Experimental Procedures." The data are the mean
values ± S.E. of four experiments performed in duplicate.
|
|
Thus, we observed a pronounced difference in the time course of protein
tyrosine nitration and NO/O 2 formation such that nitration
started to increase at a time when the rates of NO/O 2 had
already declined close to basal levels. These results argue against
peroxynitrite as a mediator of tyrosine nitration in activated macrophages. However, because of the apparent lack of peroxynitrite formation, as evident from the lack of significant DHR oxidation by
activated cells, the data do not exclude that peroxynitrite, if
produced, is capable of nitrating cellular proteins. To clarify this
issue, we treated IFN- /LPS-activated macrophages with PMA, which is
known to trigger O 2 formation through activation of protein
kinase C (29). This protocol was expected to result in an intracellular
co-generation of both NO (through induction of NO synthase) and
O 2 (through activation of protein kinase C). Fig.
4A shows that PMA (0.5 µM) led to ~2-fold increase in the rates of DHR
oxidation from 2.6 ± 0.1 to 5.4 ± 0.2 pmol × min 1 × mg 1 after 30 min. This effect of
PMA was sensitive to inhibition of NO synthase and protein kinase C
with L-NNA (1 mM) and H-7 (30 µM),
respectively (Fig. 4B). These data indicated that
co-activation of macrophages with IFN- /LPS and PMA resulted in
formation of peroxynitrite, detectable as increased rates of DHR
oxidation. However, as shown in Fig. 4C, this apparent
peroxynitrite formation was not accompanied by an increase in the
yields of protein nitration, measured 3.5 h after the addition of
PMA, i.e. 9 h after IFN- /LPS. Note that the lack of
effect of IFN- /LPS on nitration after 9 h of incubation is in
accordance with the results shown in Fig. 3.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of PMA on DHR oxidation and tyrosine
nitration by IFN- /LPS-activated
macrophages. A, macrophages were incubated with
IFN- /LPS for up to 9 h. After 5.5 h, the cells were
treated with either vehicle (open symbols) or 0.5 µM PMA (filled symbols). At the indicated time
points, oxidation of DHR was determined photometrically as described
under "Experimental Procedures." The data are the mean values ± S.E. of 3-5 experiments. B, experimental conditions were
as in panel A. Where indicated, L-NNA (0.1 mM)
or H-7 (30 µM) were added together with PMA (0.5 µM) 5.5 h after IFN- /LPS. The oxidation of DHR
was determined 30 min later, i.e. 6 h after
IFN- /LPS. The data are the mean values ± S.E. of three
experiments. C, levels of 3-nitrotyrosine (measured as
N-AcATyr derivative) in cultured macrophages, treated as in
panels A and B (9-h IFN- /LPS and 3.5-h PMA).
The data are the mean values ± S.E. of nine experiments.
|
|
Evidence for the Involvement of a Nitrite/Peroxidase Pathway in
Tyrosine Nitration--
So far, the results indicated that macrophages
activated with typical NO synthase inducers did not produce significant
amounts of peroxynitrite unless the NADPH oxidase pathway was
additionally stimulated to generate O 2. The finding that
peroxynitrite even when produced did not trigger significant nitration
extended our observations made previously with cell-free systems and
free tyrosine (7, 8) to protein nitration in intact cells. Based on
these data, we speculated that a nitrite/peroxidase pathway (5) rather than peroxynitrite may be responsible for protein tyrosine nitration in
activated macrophages.
The known peroxidase pathways of tyrosine nitration do all utilize
nitrite as a substrate (5). Thus, assuming the involvement of such a
pathway in nitration would imply that induction of macrophage NO
synthase with IFN- /Zy or IFN- /LPS is mimicked by treatment of the
cells with nitrite. To address this issue, we measured N-AcATyr levels in non-activated macrophages treated for
5 h with increasing concentrations of nitrite. As shown in Fig.
5A, incubation with 20-100
µM nitrite led to a 3-4-fold increase in nitration. The
amount of N-AcATyr in the nitrite-treated cells (100-150
pg × mg 1) was clearly less than in
IFN- /Zy-activated cells but identical to that measured 24 h
after activation of the macrophages with IFN- /LPS (see Fig. 3). A
time course of nitration in response to 20 µM nitrite is
shown in Fig. 5B.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of nitrite on tyrosine nitration by
non-activated macrophages. A, macrophages were
incubated in phenol red-free Dulbecco's modified Eagle's medium with
or without the indicated concentrations of nitrite for 5 h
followed by the determination of protein-bound 3-nitrotyrosine as
N-AcATyr derivative by HPLC and electrochemical detection as
described under "Experimental Procedures." The data are mean
values ± S.E. of three experiments performed in duplicates.
B, time course of nitration in response to 20 µM nitrite. The experimental conditions were as in
panel A.
|
|
In another set of experiments we studied the effects of
peroxynitrite/O 2 scavengers, peroxidase inhibitors, and
catalase. To minimize nonspecific and/or cytotoxic effects such as the
described inhibition of NO formation by manganese porphyrins and
catalase (30, 31), the compounds were added 14-15 h after IFN- /Zy followed by 9-10 h of incubation (24 h total) and subsequent
determination of protein-bound 3-nitrotyrosine. To account for this
protocol, the results shown in Fig. 6 are
expressed as the rates of N-AcATyr formation (pg × h 1 × mg 1) during the 9-10 h of treatment
(i.e. from 14-15 to 24 h after the addition of
IFN- /Zy). Under control conditions, this rate was 15.1 ± 2.38 pg × h 1 × mg 1. NaN3 and
KCN (0. 25 mM each), the most commonly used inhibitors of
all types of heme peroxidases (32), reduced the rate of
N-AcATyr formation to 2.90 ± 2.50 and 7.03 ± 4.68 pg × h 1 × mg 1, respectively.
The effect of NaN3 was statistically significant (p < 0.05). Peroxidase-catalyzed nitration was
reported to be strictly dependent on H2O2 (12).
Indeed, tyrosine nitration by activated macrophages was completely
blocked by incubation of the activated cells with PEG-Cat ( 1.23 ± 1.99 pg × h 1 × mg 1). In contrast,
tyrosine nitration was not significantly affected by the
peroxynitrite/O 2 scavengers methionine (0.25 mM)
and MnTBAP (50 µM) (33, 34).

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of peroxidase inhibitors and
radical scavengers on tyrosine nitration by
IFN- /Zy-activated macrophages.
Macrophages were activated with IFN- /Zy in phenol red-free
Dulbecco's modified Eagle's medium. After 14-15 h, methionine (0.25 mM), MnTBAP (50 µM), KCN, (0.25 mM), NaN3 (0.25 mM), or PEG-Cat
(2000 units/ml) were added to the medium followed by incubation of the
cells for a further 9-10 h (24 h total), determination of
protein-bound 3-nitrotyrosine as the N-AcATyr derivative by
HPLC, and electrochemical detection as described under "Experimental
Procedures." The results are expressed as rates of
N-AcATyr formation (pg of N-AcATyr × h 1 × mg 1), assuming linear changes during
the 9-10 h of incubation with scavengers or inhibitors. The data (mean
values ± S.E.; n = 3) were statistically
evaluated by analysis of variance; significant differences
(Fisher's protected least significant difference test;
p < 0.05) are indicated with an
asterisk.
|
|
The results obtained by HPLC determination of N-AcATyr were
corroborated by immunostaining of the cells with a monoclonal 3-nitrotyrosine antibody. As shown in Fig.
7, treatment of macrophages with 1 mM peroxynitrite (panel A) or activation with
IFN- /Zy for 24 h (panel B) resulted in pronounced
staining of the cells. Although removal of H2O2
with PEG-Cat or inhibition of peroxidases (KCN, NaN3)
(panels E-G) resulted in a significant reduction of the
staining intensity, scavenging of O 2 or peroxynitrite with MnTBAP or methionine, respectively (panels C and
D), was much less effective. The results confirm the
quantitative data shown in Fig. 6, suggesting that a peroxidase/nitrite
pathway rather than peroxynitrite was responsible for tyrosine
nitration in our experiments.

View larger version (157K):
[in this window]
[in a new window]
|
Fig. 7.
3-Nitrotyrosine staining of
IFN- /Zy-activated macrophages treated with
peroxidase inhibitors and radical scavengers. Macrophages were
activated with IFN- /Zy and treated with inhibitors or scavengers as
described in the legend to Fig. 6, followed by immunostaining (see
"Experimental Procedures" for details). For the positive control,
the cells were treated with 1 mM authentic peroxynitrite
(A). B, IFN- /Zy; C, IFN- /Zy + methionine (0.25 mM); D, IFN- /Zy + MnTBAP (50 µM); E, IFN- /Zy + KCN (0.25 mM); F, IFN- /Zy + NaN3 (0.25 mM);
G, IFN- /Zy + PEG-Cat (2000 units/ml); H,
non-activated cells.
|
|
Among several heme peroxidases, myeloperoxidase appeared to be a likely
candidate catalyzing
nitrite/H2O2-dependent tyrosine nitration, but it is unclear whether this enzyme occurs in RAW 264.7 macrophages (35, 36). We attempted to clarify the possible involvement
of myeloperoxidase in protein nitration using the fairly selective
myeloperoxidase inhibitor 4-aminobenzoic acid hydrazide (32). However,
this drug reduced the apparent N-AcATyr levels even below
basal levels (data not shown), presumably because of an interference
with 3-nitrotyrosine derivatization and/or electrochemical detection of
the N-AcATyr derivative. Moreover, several published
myeloperoxidase activity assays yielded negative results. To allow a
more sensitive detection of this enzyme, we used a selective
myeloperoxidase antibody (37, 38) for immunoblotting of macrophage
homogenates. As illustrated by a representative blot shown in Fig.
8, the antiserum recognized a protein
with an apparent molecular mass of ~57 kDa, which comigrated with the 57-kDa band of purified human myeloperoxidase (lane 4).
Similar amounts of the protein were found in non-activated macrophages (lane 1) and in cells activated with IFN- /LPS (lane
2) or IFN- /Zy (lane 3). These results suggest that
RAW 264.7 macrophages contain small amounts of myeloperoxidase that
might contribute to tyrosine nitration upon cytokine activation of the
L-arginine/NO pathway in these cells.

View larger version (83K):
[in this window]
[in a new window]
|
Fig. 8.
Detection of myeloperoxidase in lysates of
murine RAW 264.7 macrophages by immunoblotting. SDS-polyacrylamide
gel electrophoresis and immunoblotting were performed with 0.2 mg of
cell protein (lanes 1-3) and 2 ng of purified human
myeloperoxidase (lane 4) as described under "Experimental
Procedures." Lane 1, non-activated cells; lane
2, IFN- /LPS-activated cells (24 h); lane 3,
IFN- /Zy-activated cells (24 h); lane 4, purified human
myeloperoxidase. The blot shown is representative of four.
|
|
 |
DISCUSSION |
In the present study we investigated the mechanisms of protein
tyrosine nitration in activated RAW 264.7 murine macrophages with a
special focus on the potential involvement of peroxynitrite and heme
peroxidases. In contrast to an earlier report (39), our data do not
support the view that peroxynitrite is a major reactive nitrogen
species formed by macrophages activated with either IFN- /Zy or
IFN- /LPS. With both combinations of stimuli, we observed a
pronounced release of NO and accumulation of nitrite in the cell
culture supernatant. Although maximal rates of NO release were observed
6-8 h after stimulation, release of O 2 was maximal at much
earlier time points, i.e. 1-3 h after stimulation, and then
rapidly declined. It was conceivable that the decline in the rates of
O 2 release reflected the rapid reaction of O 2 with NO
formed by low levels of induced NO synthase. However, we observed no
considerable increase in the rates of DHR oxidation, which remained
about 10-fold lower than O 2 release at all time points (1-3
versus 10-25 pmol × min 1 × mg 1), indicating that peroxynitrite was not a major
reactive nitrogen species released from activated macrophages. These
results do not exclude that peroxynitrite was formed at low
steady-state concentrations inside the cells and rapidly consumed by
scavengers, e.g. GSH, ascorbate, or urate, but they argue
against the common view that large amounts of peroxynitrite are
released from activated macrophages to kill adjacent target cells. In
fact, there are a few previous studies suggesting that the killing of
pathogens and tumor cells by activated macrophages is mediated by NO
rather than peroxynitrite (40-42).
Our data on intracellular protein tyrosine nitration suggest that
peroxynitrite, even if produced, does not contribute to nitration in
activated macrophages. When cells were treated with either IFN- /Zy
or IFN- /LPS, formation of protein-bound 3-nitrotyrosine was
considerably delayed and became significant only when the production of
NO/nitrite had virtually ceased, indicating that nitration was not
dependent on the presence of active NO synthase and, thus, not mediated
by peroxynitrite. This conclusion is further supported by our results
obtained with the peroxynitrite scavengers methionine and MnTBAP, both
of which had no considerable effects on nitration (cf. Figs.
6 and 7). Co-stimulation of macrophages with IFN- /LPS and the
phorbol ester PMA, which triggers O 2 release through
activation of protein kinase C (29), led to a significant increase in
DHR oxidation that was sensitive to the NO synthase and protein kinase
C inhibitors L-NNA and H-7, respectively. Thus, the simultaneous
generation of NO and O 2 does indeed result in the formation
of peroxynitrite that is detectable as DHR oxidation. However, despite
this apparent continuous release of peroxynitrite over 4 h, the
addition of PMA to IFN- /LPS-activated macrophages did not result in
increased protein tyrosine nitration even though treating the cells
with authentic peroxynitrite led to fairly high levels of protein-bound
3-nitrotyrosine. These data agree well with previous in
vitro findings showing that, in contrast to bolus addition of
authentic peroxynitrite, the continuous generation of NO/O 2
from various donor systems does not nitrate free tyrosine (6-10).
Based on kinetic simulations, we proposed that the poor nitrating
efficiency of NO/O 2 may be a consequence of the resulting relatively low peroxynitrite steady-state concentrations, a condition under which dimerization of tyrosyl radicals to form dityrosine out-competes nitration, i.e. the reaction of tyrosyl
radicals with ·NO2 (8). The present results
suggest that this conclusion is not confined to test tube chemistry but
also holds for the chemical reactivity of the NO/O 2/tyrosine
system in intact cells.
The time course of 3-nitrotyrosine formation indicated that the
nitration reaction was dependent on the intracellular levels of
nitrite, the stable oxidation product of NO. Indeed, treatment of
non-stimulated macrophages with nitrite led to formation of similar
amounts of 3-nitrotyrosine as activation of the cells with IFN- /LPS.
The ~3-fold greater nitrating efficiency of IFN- /Zy, despite
similar rates of NO formation, suggests that additional factors
contribute to tyrosine nitration. Several analytical methods applied
previously for the determination of 3-nitrotyrosine in cell and tissue
extracts were shown to yield false positive results in the presence of
nitrite (4, 5). However, the fairly sophisticated method described by
Shigenaga et al. (24) that we used in this study involves
rigorous removal of nitrite and showed no increase in the
N-AcATyr levels when cell homogenates were treated with 0.1 mM nitrite before sample preparation (data not shown). The nitrite dependence of tyrosine nitration pointed to the involvement of
a heme peroxidase as reported previously for nitration in neutrophils (13) and eosinophils (14). This assumption was confirmed by the
complete inhibition of 3-nitrotyrosine formation upon removal of
H2O2 with PEG-CAT and the pronounced inhibitory
effect of the heme-site peroxidase inhibitor NaN3.
Together, these data strongly suggest that an as yet unidentified
peroxidase catalyzes tyrosine nitration in cytokine-activated RAW 264.7 macrophages. Similar evidence against peroxynitrite as a mediator of
tyrosine nitration was recently obtained with primary murine peritoneal
macrophages activated in vitro with IFN- /LPS as well as
macrophages isolated from mice subjected to systemic inflammation by
treatment with heat-inactivated Corynebacterium
parvum.2
The occurrence of heme peroxidases in macrophages is still a
controversial issue. It has been shown that myeloperoxidase activity declines rapidly during differentiation of monocytes into macrophages (43), but peroxidase activity was detected in several types of resident
tissue macrophages, such as rodent and human alveolar as well as
peritoneal macrophages (44-47). Unlike monocytes, which express
peroxidase in the primary lysosomes (48), resident macrophages contain
peroxidase activity in the rough endoplasmic reticulum and the
perinuclear cisterna (48-50). It has been suggested that macrophage
peroxidase activity results from acquisition of exogenous peroxidases
by vesicular transport or phagocytosis of peroxidase-positive cells
(51). However, myeloperoxidase mRNA has been isolated from
thioglycollate-elicited mouse peritoneal macrophages, indicating that
myeloperoxidase gene expression is inducible in macrophages by selected
immunological stimuli (52). This is further indicated by a recent study
showing that granulocyte macrophage colony-stimulating factor
up-regulates expression of active myeloperoxidase in macrophages residing in atherosclerotic lesions (53). The macrophage cell line RAW
264.7 that we used in this study was established from murine peritoneal
macrophages elicited by the intraperitoneal injection of Abelson
leukemia virus. Thus, it is conceivable that myeloperoxidase is indeed
expressed in this cell line, as suggested by our immunoblot analyses.
So far, macrophage heme peroxidases have been only poorly characterized
(54), and further work is required to clarify the role of these enzymes
in macrophage-dependent nitration and cytotoxicity.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Ernst Malle for helpful advice
on the immunological detection of myeloperoxidase. The excellent
technical assistance of Margit Rehn and Silke Nolden is gratefully acknowledged.
 |
FOOTNOTES |
*
This work was supported by the Fonds zur Förderung der
Wissenschaftlichen Forschung in Austria.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of an Austrian Academy of Sciences APART fellowship
(APART 7/98).
§
To whom correspondence should be addressed. Tel.: 43-316-380-5567;
Fax: 43-316-380-9890; E-mail: mayer@kfunigraz.ac.at.
Published, JBC Papers in Press, June 25, 2001, DOI 10.1074/jbc.M100585200
2
S. Pfeiffer, A. Lass, K. Schmidt, and B. Mayer,
FASEB J., in press.
 |
ABBREVIATIONS |
The abbreviations used are:
HPLC, high
performance liquid chromatography;
N-AcATyr, N-acetyl 3-aminotyrosine;
DHR, dihydrorhodamine 123;
LPS, lipopolysaccharide;
MnTBAP, manganese (III) tetrakis(4-benzoic acid)
porphyrin;
L-NNA, NG-nitro-L-arginine;
NO, nitric
oxide;
O 2, superoxide anion radical;
PBS, phosphate-buffered
saline;
PEG-Cat, polyethylene glycol-labeled catalase;
PEG-SOD, PEG-labeled superoxide dismutase;
PMA, phorbol 12-myristate 13-acetate;
TBST, Tris-buffered saline containing Tween 20;
Zy, zymosan A;
IFN, interferon.
 |
REFERENCES |
| 1.
|
Mayer, B.,
and Hemmens, B.
(1997)
Trends Biochem. Sci.
22,
453-498
|
| 2.
|
Beckman, J. S.,
and Koppenol, W. H.
(1996)
Am. J. Physiol. Cell Physiol.
40,
C1424-C1437
|
| 3.
|
Ischiropoulos, H.
(1998)
Arch. Biochem. Biophys.
356,
1-11
|
| 4.
|
Halliwell, B.,
Zhao, K.,
and Whiteman, M.
(1999)
Free Radical Res.
31,
651-669
|
| 5.
|
van der Vliet, A.,
Eiserich, J. P.,
Shigenaga, M. K.,
and Cross, C. E.
(1999)
Am. J. Respir. Crit. Care Med.
160,
1-9
|
| 6.
|
van der Vliet, A.,
Eiserich, J. P.,
O'Neill, C. A.,
Halliwell, B.,
and Cross, C. E.
(1995)
Arch. Biochem. Biophys.
319,
341-349
|
| 7.
|
Pfeiffer, S.,
and Mayer, B.
(1998)
J. Biol. Chem.
273,
27280-27285
|
| 8.
|
Pfeiffer, S.,
Schmidt, K.,
and Mayer, B.
(2000)
J. Biol. Chem.
275,
6346-6352
|
| 9.
|
Goldstein, S.,
Czapski, G.,
Lind, J.,
and Merenyi, G.
(2000)
J. Biol. Chem.
275,
3031-3036
|
| 10.
|
Hodges, G. R.,
Marwaha, J.,
Paul, T.,
and Ingold, K. U.
(2000)
Chem. Res. Toxicol.
13,
1287-1293
|
| 11.
|
Sawa, T.,
Akaike, T.,
and Maeda, H.
(2000)
J. Biol. Chem.
275,
32467-32474
|
| 12.
|
van der Vliet, A.,
Eiserich, J. P.,
Halliwell, B.,
and Cross, C. E.
(1997)
J. Biol. Chem.
272,
7617-7625
|
| 13.
|
Eiserich, J. P.,
Hristova, M.,
Cross, C. E.,
Jones, A. D.,
Freeman, B. A.,
Halliwell, B.,.,
and van der Vliet, A.
(1998)
Nature
391,
393-397
|
| 14.
|
Wu, W.,
Chen, Y.,
and Hazen, S. L.
(1999)
J. Biol. Chem.
274,
25933-25944
|
| 15.
|
Shigenaga, M. K.,
Lee, H. H.,
Blount, B. C.,
Christen, S.,
Shigeno, E. T.,
Yip, H.,
and Ames, B. N.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
3211-3216
|
| 16.
|
Beckman, J. S.,
Minor, R. L.,
White, C. W.,
Repine, J. E.,
Rosen, G. M.,
and Freeman, B. A.
(1988)
J. Biol. Chem.
263,
6884-6892
|
| 17.
|
Garthwaite, J.,
Southam, E.,
Boulton, C. L.,
Nielsen, E. B.,
Schmidt, K.,
and Mayer, B.
(1995)
Mol. Pharmacol.
48,
184-188
|
| 18.
|
Pfeiffer, S.,
Gorren, A. C. F.,
Schmidt, K.,
Werner, E. R.,
Hansert, B.,
Bohle, D. S.,
and Mayer, B.
(1997)
J. Biol. Chem.
272,
3465-3470
|
| 19.
|
Schmidt, K.,
and Mayer, B.
(1997)
in
Nitric Oxide Protocols
(Titherage, M. A., ed)
, pp. 101-109, Humana Press Inc., Totowa, NJ
|
| 20.
|
Lass, A.,
Argawal, S.,
and Sohal, R. S.
(1997)
J. Biol. Chem.
272,
19199-19204
|
| 21.
|
Ernster, L.,
and Dallner, G.
(1995)
Biochim. Biophys. Acta
1271,
195-204
|
| 22.
|
De la Harpe, J.,
and Nathan, C. F.
(1985)
J. Immunol. Methods
78,
323-336
|
| 23.
|
Crow, J. P.
(1997)
Nitric Oxide
1,
145-157
|
| 24.
|
Shigenaga, M. K.
(1999)
Methods Enzymol.
301,
27-40
|
| 25.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
|
| 26.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 27.
|
Hibbs, J. B.,
Vavrin, Z.,
and Taintor, R. R.
(1987)
J. Immunol.
138,
550-565
|
| 28.
|
Stuehr, D. J.,
Gross, S. S.,
Sakuma, I.,
Levi, R.,
and Nathan, C. F.
(1989)
J. Exp. Med.
169,
1011-1020
|
| 29.
|
Kiyotaki, C.,
and Bloom, B. R.
(1984)
J. Immunol.
133,
923-931
|
| 30.
|
Pfeiffer, S.,
Schrammel, A.,
Koesling, D.,
Schmidt, K.,
and Mayer, B.
(1998)
Mol. Pharmacol.
53,
795-800
|
| 31.
|
Li, Y.,
Severn, A.,
Rogers, M. V.,
Palmer, R. M. J.,
Moncada, S.,
and Liew, F. Y.
(1992)
Eur. J. Immunol.
22,
441-446
|
| 32.
|
Kettle, A. J.,
and Winterbourn, C. C.
(1997)
Redox Rep.
3,
3-15
|
| 33.
|
Faulkner, K. M.,
Liochev, S. I.,
and Fridovich, I.
(1994)
J. Biol. Chem.
269,
23471-23476
|
| 34.
|
Ferrer-Sueta, G.,
BatinicHaberle, I.,
Spasojevic, I.,
Fridovich, I.,
and Radi, R.
(1999)
Chem. Res. Toxicol.
12,
442-449
|
| 35.
|
Kalns, J.,
Parker, J.,
Bruno, J.,
Holwitt, E.,
Piepmeier, E.,
and Kiel, J.
(1998)
Nitric Oxide
2,
366-374
|
| 36.
|
Bruno, J. G.,
Herman, T. S.,
Cano, V. L.,
Stribling, L.,
and Kiel, J. L.
(1999)
In Vitro Cell Dev. Biol. Anim.
35,
376-382
|
| 37.
|
Daugherty, A.,
Dunn, J. L.,
Rateri, D. L.,
and Heinecke, J. W.
(1994)
J. Clin. Invest.
94,
437-444
|
| 38.
|
Malle, E.,
Waeg, G.,
Schreiber, R.,
Gröne, E. F.,
Sattler, W.,
and Gröne, H.-J.
(2000)
Eur. J. Biochem.
267,
1-10
|
| 39.
|
Ischiropoulos, H.,
Zhu, L.,
and Beckman, J. S.
(1992)
Arch. Biochem. Biophys.
298,
446-451
|
| 40.
|
Assreuy, J.,
Cunha, F. Q.,
Epperlein, M.,
Noronha-Dutra, A.,
O'Donnell, C. A.,
Liew, F. Y.,
and Moncada, S.
(1994)
Eur. J. Immunol.
24,
672-676
|
| 41.
|
Murray, H. W.,
and Nathan, C. F.
(1999)
J. Exp. Med.
189,
741-746
|
| 42.
|
Fricker, S. P.,
Slade, E.,
and Powell, N. A.
(1999)
Anticancer Res.
19,
553-556
|
| 43.
|
Nakagawara, A.,
Nathan, C. F.,
and Cohn, Z. A.
(1981)
J. Clin. Invest.
68,
1243-1252
|
| 44.
|
Paul, B. B.,
Strauss, R. R.,
Selvaraj, R. J.,
and Sbarra, A. J.
(1973)
Science
181,
849-850
|
| 45.
|
Strauss, R. R.,
Friedman, H.,
Mills, L.,
and Zayon, G.
(1975)
Nature
255,
343-344
|
| 46.
|
Heinecke, J. W.,
Li, W.,
Daehnke, H. L., III,
and Goldstein, J. A.
(1993)
J. Biol. Chem.
268,
4069-4077
|
| 47.
|
Ueda, T.,
Kohli, Y.,
Katho, Y. A. T.,
Ogasawara, T.,
and Kashima, Y. N. K.
(1995)
Histochem.
103,
11-17
|
| 48.
|
Biggar, W. D.,
and Sturgess, J. M.
(1976)
Lab. Invest.
34,
31-42
|
| 49.
|
Bodel, P. T.,
Nichols, B. A.,
and Bainton, D. F.
(1977)
J. Exp. Med.
145,
264-274
|
| 50.
|
Bodel, P. T.,
Nichols, B. A.,
and Bainton, D. F.
(1978)
Am. J. Pathol.
91,
107-117
|
| 51.
|
Warnock, M. L.,
Sniezek, M.,
and Shellito, J.
(1987)
Am. J. Pathol.
128,
171-180
|
| 52.
|
Reynolds, W. F.,
Rhees, J.,
Maciejekski, D.,
Paladino, T.,
Sieburg, H.,
Maki, R. A.,
and Masliah, E.
(1999)
Exp. Neurol.
155,
31-41
|
| 53.
|
Sugiyama, S.,
Okada, Y.,
Sukhova, G. K.,
Virmani, R.,
Heinecke, J. W.,
and Libby, P.
(2001)
Am. J. Pathol.
158,
879-891
|
| 54.
|
de Mendez, I.,
Randall Young, K.,
Bignon, J.,
and Lambre, C. R.
(1991)
Arch. Biochem. Biophys.
289,
319-323
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Beretta, K. Gruber, A. Kollau, M. Russwurm, D. Koesling, W. Goessler, W. M. Keung, K. Schmidt, and B. Mayer
Bioactivation of Nitroglycerin by Purified Mitochondrial and Cytosolic Aldehyde Dehydrogenases
J. Biol. Chem.,
June 27, 2008;
283(26):
17873 - 17880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Molina-Cruz, R. J. DeJong, B. Charles, L. Gupta, S. Kumar, G. Jaramillo-Gutierrez, and C. Barillas-Mury
Reactive Oxygen Species Modulate Anopheles gambiae Immunity against Bacteria and Plasmodium
J. Biol. Chem.,
February 8, 2008;
283(6):
3217 - 3223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Thomas, L. A. Ridnour, M. G. Espey, S. Donzelli, S. Ambs, S. P. Hussain, C. C. Harris, W. DeGraff, D. D. Roberts, J. B. Mitchell, et al.
Superoxide Fluxes Limit Nitric Oxide-induced Signaling
J. Biol. Chem.,
September 8, 2006;
281(36):
25984 - 25993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Deeb, H. Shen, C. Gamss, T. Gavrilova, B. D. Summers, R. Kraemer, G. Hao, S. S. Gross, M. Laine, N. Maeda, et al.
Inducible Nitric Oxide Synthase Mediates Prostaglandin H2 Synthase Nitration and Suppresses Eicosanoid Production
Am. J. Pathol.,
January 1, 2006;
168(1):
349 - 362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Herzog, Y. Maekawa, T. P. Cirrito, B. S. Illian, and E. R. Unanue
Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells
PNAS,
May 31, 2005;
102(22):
7928 - 7933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kumar, L. Gupta, Y. S. Han, and C. Barillas-Mury
Inducible Peroxidases Mediate Nitration of Anopheles Midgut Cells Undergoing Apoptosis in Response to Plasmodium Invasion
J. Biol. Chem.,
December 17, 2004;
279(51):
53475 - 53482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pennathur, C. Bergt, B. Shao, J. Byun, S. Y. Kassim, P. Singh, P. S. Green, T. O. McDonald, J. Brunzell, A. Chait, et al.
Human Atherosclerotic Intima and Blood of Patients with Established Coronary Artery Disease Contain High Density Lipoprotein Damaged by Reactive Nitrogen Species
J. Biol. Chem.,
October 8, 2004;
279(41):
42977 - 42983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Gonzalez, J.-C. Drapier, and C. Bouton
Endogenous Nitration of Iron Regulatory Protein-1 (IRP-1) in Nitric Oxide-producing Murine Macrophages: FURTHER INSIGHT INTO THE MECHANISM OF NITRATION IN VIVO AND ITS IMPACT ON IRP-1 FUNCTIONS
J. Biol. Chem.,
October 8, 2004;
279(41):
43345 - 43351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Park, T. J. Geddes, J. A. Javitch, and D. M. Kuhn
Dopamine Prevents Nitration of Tyrosine Hydroxylase by Peroxynitrite and Nitrogen Dioxide: IS NITROTYROSINE FORMATION AN EARLY STEP IN DOPAMINE NEURONAL DAMAGE?
J. Biol. Chem.,
August 1, 2003;
278(31):
28736 - 28742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Schmidt, N. Youhnovski, A. Daiber, A. Balan, M. Arsic, M. Bachschmid, M. Przybylski, and V. Ullrich
Specific Nitration at Tyrosine 430 Revealed by High Resolution Mass Spectrometry as Basis for Redox Regulation of Bovine Prostacyclin Synthase
J. Biol. Chem.,
April 4, 2003;
278(15):
12813 - 12819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Halpern, H. Holubec, J. A. Dominguez, Y. G. Meza, C. S. Williams, M. C. Ruth, R. S. McCuskey, and B. Dvorak
Hepatic inflammatory mediators contribute to intestinal damage in necrotizing enterocolitis
Am J Physiol Gastrointest Liver Physiol,
April 1, 2003;
284(4):
G695 - G702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pfeiffer and B. Mayer
Protein tyrosine nitration and peroxynitrite: Reply
FASEB J,
December 1, 2002;
16(14):
1854 - 1854.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. V. Turko and F. Murad
Protein Nitration in Cardiovascular Diseases
Pharmacol. Rev.,
December 1, 2002;
54(4):
619 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Deeb, M. J. Resnick, D. Mittar, T. McCaffrey, D. P. Hajjar, and R. K. Upmacis
Tyrosine nitration in prostaglandin H2 synthase
J. Lipid Res.,
October 1, 2002;
43(10):
1718 - 1726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Thomas, M. G. Espey, M. P. Vitek, K. M. Miranda, and D. A. Wink
Protein nitration is mediated by heme and free metals through Fenton-type chemistry: An alternative to the NO/O2- reaction
PNAS,
October 1, 2002;
99(20):
12691 - 12696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Espey, S. Xavier, D. D. Thomas, K. M. Miranda, and D. A. Wink
Direct real-time evaluation of nitration with green fluorescent protein in solution and within human cells reveals the impact of nitrogen dioxide vs. peroxynitrite mechanisms
PNAS,
March 19, 2002;
99(6):
3481 - 3486.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|